These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10539888)
1. Factitious methemoglobinemia. Carr KM; Elias L; Caruana LC; Rabinowitz I Am J Hematol; 1999 Nov; 62(3):196-7. PubMed ID: 10539888 [TBL] [Abstract][Full Text] [Related]
2. Very late recovery of dapsone-induced methemoglobinemia. Wieringa A; Bethlehem C; Hoogendoorn M; van der Maten J; van Roon EN Clin Toxicol (Phila); 2014 Jan; 52(1):80-1. PubMed ID: 24308869 [No Abstract] [Full Text] [Related]
3. Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis. Gallardo CA; Fan BE; Lim KGE; Kuperan P Am J Hematol; 2021 Dec; 96(12):1715-1716. PubMed ID: 33524190 [No Abstract] [Full Text] [Related]
4. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. Talarico JF; Metro DG J Clin Anesth; 2005 Nov; 17(7):568-70. PubMed ID: 16297761 [TBL] [Abstract][Full Text] [Related]
5. [Lip cyanosis in dapsone therapy: should the dosage be reduced?]. Stichtenoth D MMW Fortschr Med; 2012 Apr; 154(6):32. PubMed ID: 22642026 [No Abstract] [Full Text] [Related]
7. Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion. Craig D; Cadden IS; Gormley WP; Riley MS; Jones FG; McMullin MF Int J Clin Pract; 2000 Apr; 54(3):194-6. PubMed ID: 10829363 [TBL] [Abstract][Full Text] [Related]
8. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite. Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178 [TBL] [Abstract][Full Text] [Related]
9. Dapsone-induced methemoglobinemia: case report and literature review. Zosel A; Rychter K; Leikin JB Am J Ther; 2007; 14(6):585-7. PubMed ID: 18090884 [TBL] [Abstract][Full Text] [Related]
10. High-dose vitamin C management in dapsone-induced methemoglobinemia. Park SY; Lee KW; Kang TS Am J Emerg Med; 2014 Jun; 32(6):684.e1-3. PubMed ID: 24439259 [TBL] [Abstract][Full Text] [Related]
11. Methemoglobinemia from dapsone therapy for a suspected brown spider bite. Iserson KV J Emerg Med; 1985; 3(4):285-8. PubMed ID: 4093581 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. Ashurst JV; Wasson MN; Hauger W; Fritz WT J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649 [TBL] [Abstract][Full Text] [Related]
17. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. Turner MD; Karlis V; Glickman RS Anesth Prog; 2007; 54(3):115-7. PubMed ID: 17900210 [TBL] [Abstract][Full Text] [Related]
18. Methemoglobinemia as a complication of topical dapsone. Swartzentruber GS; Yanta JH; Pizon AF N Engl J Med; 2015 Jan; 372(5):491-2. PubMed ID: 25629756 [No Abstract] [Full Text] [Related]
19. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Plotkin JS; Buell JF; Njoku MJ; Wilson S; Kuo PC; Bartlett ST; Howell C; Johnson LB Liver Transpl Surg; 1997 Mar; 3(2):149-52. PubMed ID: 9346728 [TBL] [Abstract][Full Text] [Related]
20. Methemoglobinemia as a complication of topical dapsone. Watton C; Smith K; Carter E N Engl J Med; 2015 Jan; 372(5):492. PubMed ID: 25629755 [No Abstract] [Full Text] [Related] [Next] [New Search]